Document is current
Any future updates will be listed below
-
Authors
Ikeda, Yuika https://orcid.org/0000-0002-5303-3186
Teixeira, Bruno Casaes https://orcid.org/0000-0003-2366-0960
Laurent, Thomas https://orcid.org/0000-0002-7053-8469
Yamamoto, Tsunehisa https://orcid.org/0000-0002-5241-9482
-
Funding
Funding for this research was provided by:
Bristol Myers Squibb
- License Information
-
More Information
Article History
Received: 24 March 2025
Accepted: 26 June 2025
First Online: 19 July 2025
Declarations
:
: Yuika Ikeda, Bruno Casaes Teixeira, Thomas Laurent, and Tsunehisa Yamamoto are employees of Bristol Myers Squibb, and own stocks in Bristol Myers Squibb.
: This study used de-identified claims/EMR data and, therefore, did not require ethics committee review. In addition, this study did not require informed consent to be obtained from patients. This study was conducted in accordance with the International Society for Pharmacoepidemiology Guidelines for Good Pharmacoepidemiology Practices and applicable regulatory requirements []. This article is based on information from an existing database and does not contain any new studies with human participants or animals performed by any of the authors []. Since the database is available in the public domain (), no permission was obtained to access and use the data from the database utilized in this study.
